SRX HEALTH SOLUTIONS INC (SRXH)
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
$1.51-3.21%
Close 2026-09-04 · 1-day change
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · SRXH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | FY 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | FY 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 6.5 | 6.5 | 35.0 | 54.7 | 46.0 | 42.6 | 15.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of Revenues | — | 5.0 | 5.0 | 22.0 | 39.4 | 30.6 | 26.5 | 9.7 | 9.7 | 0.0 | — | — | — | — | — | — |
| Gross Profit | — | 1.5 | 1.5 | 13.0 | 15.3 | 15.4 | 16.1 | 5.9 | — | 0.0 | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | 12.9 | 12.9 | 19.0 | 35.4 | 28.5 | 34.5 | — | — | — | — | — | — | — | — | — |
| R&D Expenses | — | — | — | 0.1 | 0.5 | 0.5 | 0.1 | — | — | — | — | — | — | — | — | — |
| Operating Income | — | (11.4) | (11.4) | (6.0) | (38.8) | (17.3) | (27.3) | (36.3) | (36.3) | (0.5) | (0.5) | (0.5) | (0.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.6 | 0.6 | 0.5 | 0.6 | — | — | — | 0.5 | 0.5 | 0.8 | 0.4 | 0.0 | 0.0 | 0.1 | 0.0 |
| Other Non-Operating Income / Expenses | — | (2.8) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | — | 8.5 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (8.6) | (8.6) | (0.2) | (39.3) | 3.4 | (59.3) | — | (1.1) | (1.1) | (1.7) | (0.9) | (0.0) | (0.1) | (0.1) | (0.0) |
| Income Tax Expense | — | — | — | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Earnings from Continuing Operations | — | (8.6) | (8.6) | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | — | (45.0) | (45.0) | (0.2) | (39.3) | 3.4 | (59.3) | (184.5) | (184.5) | (3.0) | (1.7) | (0.9) | (0.0) | (0.1) | (0.1) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (2.13) | (2.13) | (0.10) | (58.93) | 0.15 | (7.26) | — | — | — | (0.02) | (0.01) | 0.00 | 0.00 | (1.56) | (0.26) |
| Diluted EPS | — | (2.13) | (2.13) | (0.10) | (58.93) | 0.14 | (7.26) | — | — | — | (0.02) | (0.01) | 0.00 | 0.00 | (1.56) | (0.26) |
| Basic Weighted Avg Shares | 11.4 | 21.1 | 21.1 | 1.6 | 0.7 | 19.9 | 8.2 | — | 3.0 | — | 3.0 | 70.5 | 37.6 | 27.8 | 0.1 | 0.1 |
| Diluted Weighted Avg Shares | 11.4 | 21.1 | 21.1 | 1.6 | 0.7 | 21.9 | 8.2 | — | 3.0 | — | 3.0 | 70.5 | 37.6 | 27.8 | 0.1 | 0.1 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (11.4) | (11.4) | (5.8) | (37.1) | (15.6) | (25.6) | (36.2) | (36.2) | — | (0.5) | (0.5) | (0.0) | (0.0) | (0.0) | (0.0) |
| EBIT | — | (11.4) | (11.4) | (6.0) | (38.8) | (17.3) | (27.3) | (36.3) | (36.3) | (0.5) | (0.5) | (0.5) | (0.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | — | 0.0% | 1.1% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.